{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:25:57Z","timestamp":1781108757657,"version":"3.54.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T00:00:00Z","timestamp":1795132800000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007314","name":"The University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020487","name":"Break Through Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020487","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ajog.2025.06.063","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T02:42:03Z","timestamp":1751683323000},"page":"615.e1-615.e24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development and validation of a histology-specific natural history model of ovarian cancer"],"prefix":"10.1016","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7728-2227","authenticated-orcid":false,"given":"Sayaka","family":"Ishizawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Eghbalizarch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu S.","family":"Nargund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Mostafa","family":"Mousavi Janbeh Sarayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Hemmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddie","family":"Tumbarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon H.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa A.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3462-2137","authenticated-orcid":false,"given":"Iakovos","family":"Toumazis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2025.06.063_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2025.06.063_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","article-title":"Ovarian cancer","volume":"4","author":"Cho","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ajog.2025.06.063_bib3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/COC.0000000000001056","article-title":"Genomic and molecular characteristics of ovarian carcinosarcoma","volume":"46","author":"Ramphal","year":"2023","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ajog.2025.06.063_bib4","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program. SEER\u2217Stat database: Incidence - SEER Research Plus 17 Regs Data (2000 - 2020). Available at: https:\/\/seer.cancer.gov\/. Accessed July 22, 2025."},{"key":"10.1016\/j.ajog.2025.06.063_bib5","first-page":"609","article-title":"Ovarian cancer: an overview","volume":"80","author":"Roett","year":"2009","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ajog.2025.06.063_bib6","first-page":"937","article-title":"Diagnosis and management of ovarian cancer","volume":"93","author":"Doubeni","year":"2016","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ajog.2025.06.063_bib7","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program. Cancer Stat Facts: Ovarian Cancer. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html. Accessed July 22, 2025."},{"key":"10.1016\/j.ajog.2025.06.063_bib8","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2025.06.063_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejca.2017.10.015","article-title":"Outcomes from ovarian cancer screening in the PLCO trial: histologic heterogeneity impacts detection, overdiagnosis and survival","volume":"87","author":"Temkin","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajog.2025.06.063_bib10","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2025.06.063_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ebm.2011.100163","article-title":"Ovarian cancer screening has no effect on disease-specific mortality","volume":"17","author":"Menon","year":"2012","journal-title":"Evid Based Med"},{"key":"10.1016\/j.ajog.2025.06.063_bib12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","article-title":"Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","volume":"10","author":"Menon","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajog.2025.06.063_bib13","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2025.06.063_bib14","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/jnci\/djae145","article-title":"Estimating sojourn time and sensitivity of screening for ovarian cancer using a Bayesian framework","volume":"116","author":"Ishizawa","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2025.06.063_bib15","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jama.2017.19872","article-title":"Screening for cervical cancer in primary care: a decision analysis for the US preventive services task force","volume":"320","author":"Kim","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2025.06.063_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.0479","article-title":"Estimated cancer risk in females who meet the criteria to exit cervical cancer screening","volume":"8","author":"Kulasingam","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajog.2025.06.063_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1524-4733.2004.72318.x","article-title":"A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease","volume":"7","author":"Borg","year":"2004","journal-title":"Value Health"},{"key":"10.1016\/j.ajog.2025.06.063_bib18","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1001\/jama.2021.1077","article-title":"Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US Preventive Services Task Force","volume":"325","author":"Meza","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2025.06.063_bib19","first-page":"50","article-title":"Screening for lung cancer: 2023 guideline update from the American Cancer Society","volume":"74","author":"Wolf","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2025.06.063_bib20","first-page":"S51","article-title":"Chapter 5: actual and counterfactual smoking prevalence rates in the U.S. population via microsimulation","volume":"32","author":"Jeon","year":"2012","journal-title":"Risk Anal"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2025.06.063_bib21","first-page":"S99","article-title":"Chapter 8: the FHCRC lung cancer model","volume":"32","author":"Hazelton","year":"2012","journal-title":"Risk Anal"},{"key":"10.1016\/j.ajog.2025.06.063_bib22","first-page":"175","article-title":"Comparing the benefits of screening for breast cancer and lung cancer using a novel natural history model","volume":"23","author":"Lin","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ajog.2025.06.063_bib23","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/cncr.28623","article-title":"Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials","volume":"120","author":"Meza","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2025.06.063_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ajog.2025.02.029","article-title":"An updated understanding of the natural history of cervical human papillomavirus infection-clinical implications","volume":"232","author":"Lycke","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.06.063_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/jama.2017.19130","article-title":"Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012","volume":"319","author":"Plevritis","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2025.06.063_bib26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/bjc.1985.222","article-title":"A simulation model of the natural history of human breast cancer","volume":"52","author":"Koscielny","year":"1985","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2025.06.063_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211918","article-title":"A natural history model for planning prostate cancer testing: calibration and validation using Swedish registry data","volume":"14","author":"Karlsson","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2025.06.063_bib28","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/s41416-022-01904-5","article-title":"Multistate models for the natural history of cancer progression","volume":"127","author":"Cheung","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2025.06.063_bib29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/cncr.25624","article-title":"Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction","volume":"117","author":"Havrilesky","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2025.06.063_bib30","series-title":"SEER\u2217Stat database: Incidence - SEER Research Plus 17 Regs Data (1988 - 2004).","year":"2008"},{"key":"10.1016\/j.ajog.2025.06.063_bib31","unstructured":"Social Security Administration. Actuarial Life Table. Available at: https:\/\/www.ssa.gov\/oact\/STATS\/table4c6.html. Accessed July 22, 2025."},{"key":"10.1016\/j.ajog.2025.06.063_bib32","unstructured":"Kochenderfer MJ, Wheeler TA. Algorithms for optimization. Cambridge, Massachusetts: MIT Press; 2019."},{"key":"10.1016\/j.ajog.2025.06.063_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1137\/141000671","article-title":"Julia: a fresh approach to numerical computing","volume":"59","author":"Bezanson","year":"2017","journal-title":"SIAM Review"},{"key":"10.1016\/j.ajog.2025.06.063_bib34","first-page":"16","article-title":"Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells","volume":"5","author":"Testa","year":"2018","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.ajog.2025.06.063_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.humpath.2018.06.018","article-title":"Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics","volume":"80","author":"Prat","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajog.2025.06.063_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2021.102074","article-title":"Ovarian cancer survival by stage, histotype, and pre-diagnostic lifestyle factors, in the prospective UK Million Women Study","volume":"76","author":"Gaitskell","year":"2022","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ajog.2025.06.063_bib37","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2025.06.063_bib38","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2021.5746","article-title":"Colorectal cancer screening: an updated modeling study for the US preventive services task force","volume":"325","author":"Knudsen","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2025.06.063_bib39","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jama.2023.24766","article-title":"Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US preventive services task force","volume":"331","author":"Trentham-Dietz","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2025.06.063_bib40","doi-asserted-by":"crossref","first-page":"204.e1","DOI":"10.1016\/j.ajog.2024.08.023","article-title":"Cost of ovarian cancer by the phase of care in the United States","volume":"232","author":"Adjei","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.06.063_bib41","article-title":"Age-induced metabolic reprogramming underlies cancer progression","volume":"8","author":"Ilter","year":"2021","journal-title":"Mol Cell Oncol"},{"key":"10.1016\/j.ajog.2025.06.063_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","article-title":"How the ageing microenvironment influences tumour progression","volume":"20","author":"Fane","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajog.2025.06.063_bib43","first-page":"1","article-title":"Oral contraceptive use for the primary prevention of ovarian cancer","volume":"212","author":"Havrilesky","year":"2013","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"key":"10.1016\/j.ajog.2025.06.063_bib44","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium","volume":"34","author":"Wentzensen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajog.2025.06.063_bib45","unstructured":"International Agency for Research on Cancer. Review of Human Carcinogens (IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, 100). Geneva, Switzerland: World Health Organization; 2012."},{"key":"10.1016\/j.ajog.2025.06.063_bib46","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1940-6207.CAPR-14-0293","article-title":"Salpingectomy as a means to reduce ovarian cancer risk","volume":"8","author":"Daly","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.ajog.2025.06.063_bib47","doi-asserted-by":"crossref","first-page":"721.e1","DOI":"10.1016\/j.ajog.2020.04.028","article-title":"The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States","volume":"223","author":"Mandelbaum","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.06.063_bib48","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.47343","article-title":"Outcomes from opportunistic salpingectomy for ovarian cancer prevention","volume":"5","author":"Hanley","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajog.2025.06.063_bib49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1200\/OP.21.00382","article-title":"Risk-reducing bilateral salpingo-oophorectomy for ovarian cancer: a review and clinical guide for hereditary predisposition genes","volume":"18","author":"Liu","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.ajog.2025.06.063_bib50","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/AOG.0b013e3181ec5fc1","article-title":"Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer","volume":"116","author":"Berek","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.06.063_bib58","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program. SEER\u2217Stat database: Incidence - SEER Research Plus 17 Regs Data (2000 - 2020). Available at: https:\/\/seer.cancer.gov\/. Accessed July 22, 2025."},{"key":"10.1016\/j.ajog.2025.06.063_bib59","unstructured":"Social Security Administration. Actuarial Life Table. Available at: https:\/\/www.ssa.gov\/oact\/STATS\/table4c6.html. Accessed July 22, 2025."},{"key":"10.1016\/j.ajog.2025.06.063_bib60","unstructured":"Kochenderfer MJ, Wheeler TA. Algorithms for optimization. Cambridge, Massachusetts: MIT Press; 2019."},{"key":"10.1016\/j.ajog.2025.06.063_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djae145","article-title":"Estimating sojourn time and sensitivity of screening for ovarian cancer using a Bayesian framework","author":"Ishizawa","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2025.06.063_bib62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.5219","article-title":"Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions","volume":"248","author":"Wu","year":"2019","journal-title":"J Pathol"},{"key":"10.1016\/j.ajog.2025.06.063_bib63","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Automatic Control"},{"key":"10.1016\/j.ajog.2025.06.063_bib64","series-title":"flexsurv: a platform for parametric survival modeling in R. J Stat Softw","author":"Amdahl","year":"2016"},{"key":"10.1016\/j.ajog.2025.06.063_bib65","series-title":"Package \u2018missRanger\u2019","author":"Mayer","year":"2019"},{"key":"10.1016\/j.ajog.2025.06.063_bib66","series-title":"R: A language and environment for statistical computing","author":"Team","year":"2013"},{"key":"10.1016\/j.ajog.2025.06.063_bib67","first-page":"212","article-title":"A comparative study of optimization techniques for tuning a finite element model of the lung to biomechanical data","volume":"43","author":"Gayzik","year":"2007","journal-title":"Biomed Sci Instrum"},{"key":"10.1016\/j.ajog.2025.06.063_bib68","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1137\/141000671","article-title":"Julia: a fresh approach to numerical computing","volume":"59","author":"Bezanson","year":"2017","journal-title":"SIAM review"},{"key":"10.1016\/j.ajog.2025.06.063_bib69","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2025.06.063_bib70","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2025.06.063_bib71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1214\/ss\/1009213286","article-title":"Interval estimation for a binomial proportion","volume":"16","author":"Brown","year":"2001","journal-title":"Statistical Science"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825004594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825004594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:58:16Z","timestamp":1772791096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937825004594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0002937825004594"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2025.06.063","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a histology-specific natural history model of ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2025.06.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}